Relmada Therapeutics Inc (RLMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Operating Expenses | 20,333 | 10,327 | 10,221 | 18,218 | 19,076 |
| Operating Income | -20,333 | -10,327 | -10,221 | -18,218 | -19,076 |
| Other Income | 465 | 236 | 355 | 659 | 419 |
| Pre-tax Income | -19,868 | -10,092 | -9,866 | -17,560 | -18,657 |
| Net Income Continuous | -19,868 | -10,092 | -9,866 | -17,560 | -18,657 |
| Net Income | $-19,868 | $-10,092 | $-9,866 | $-17,560 | $-18,657 |
| EPS Basic Total Ops | -0.27 | -0.30 | -0.30 | -0.58 | -0.62 |
| EPS Basic Continuous Ops | -0.27 | -0.30 | -0.30 | -0.58 | -0.62 |
| EPS Diluted Total Ops | -0.27 | -0.30 | -0.30 | -0.58 | -0.62 |
| EPS Diluted Continuous Ops | -0.27 | -0.30 | -0.30 | -0.58 | -0.62 |
| EPS Diluted Before Non-Recurring Items | -0.27 | -0.30 | -0.30 | -0.58 | -0.62 |
| EBITDA(a) | $-20,333 | $-10,327 | $-10,221 | $-18,218 | $-19,076 |